To prevent the relapse or improve the quality of life for IBD patients, various therapeutic approaches to IBD have been investigated, such as using anti-tumor necrosis factor (TNF) antibodies, Janus kinase inhibitors, and immunosuppressant drugs [43,44]. This evidence concerns the gene TNF and inflammatory bowel disease.